Sep 18, 2026
Full Transcript: Icecure Medical Q2 2026 Earnings Call
Icecure Medical reported a 45% year-over-year revenue increase to $1.8 million for the first half of 2026, driven by the growth of ProSense systems and disposable probes. The company's gross margin improved to 30%, despite foreign exchange fluctuations, reflecting increased scale and improved operating leverage. Icecure Medical achieved a 70% growth in its U.S. commercial footprint, supported by expansions in key regions and international markets such as Japan, and ended the first half with approximately $12 million in cash and cash equivalents.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish